Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ resapp health limited

Ann: Medgate commences European ResAppDx trial, page-21

First 21 Last

Share
Profile

Follow
AlCp

26,231 Posts.

1705

04/03/21

11:24

Post #: 51510280
Share

Originally posted by SortedItOut ↑

Agree, the high end of upside is;
200 doctors * 20 calls a day * 50% respiratory case * 30%- 75% use Resapp (This could be wrong) * $5 a use = ~1250 uses a day = $6,250 a day or ~$2.2m annualized. I get these are high level and could move +/- reasonable % either way.

$2.2m is not even half a year of runway for company.

Still if we get anything near that upside it would trigger a massive rerate of shares.

I expect a CR once the Share price rises on any further positive news.

Expand

Medgate will attract a lot more consultation given how many respiratory consultation are done in clinic and now patient don't need to travel and wait in clinic for hours and you don't think their competitor will want to offer this unique telehealth services......

RAP Price at posting: 5.8¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 147 more messages in this thread...

First 21 Last

Add RAP (ASX) to my watchlist